Types and Distribution of Payments From Industry to Physicians in 2015

Tringale, Kathryn R.; Marshall, Deborah; Mackey, Tim K.; Connor, Michael; Murphy, James D.; Hattangadi‐Gluth, Jona A.

doi:10.1001/jama.2017.3091

Cited by 200 publications

(281 citation statements)

References 34 publications

(84 reference statements)

Supporting

Mentioning

228

Contrasting

Order By: Relevance

“…They found that male physicians, oncologists (relative to nononcologists), solo practitioners, and those in high Medicare spending regions were more likely to accept transfers. Using 2015 OPD, Tringale et al examined conditional transfers using regression analysis. They found that males and those in high Medicare spending regions accepted more transfers and that solo practitioners accepted less.…”

Section: Existing Literaturementioning

confidence: 99%

Physician characteristics, industry transfers, and pharmaceutical prescribing: Empirical evidence from medicare and the physician payment sunshine act

Brunt

2018

Health Services Research

View full text Add to dashboard Cite

Objective To evaluate physician characteristics associated with pharmaceutical industry transfers and prescribing behavior after public reporting under the Sunshine Act. Data Sources 2014‐2016 secondary data on industry transfers to physicians from the Open Payments Dataset supplemented with Medicare Part D prescription data, Medicare service data, and practice attributes from the Physician Compare Database. Study Design Using regression analysis with county/physician fixed effects, this study examines characteristics associated with the probability/magnitude of transfers and the association between transfers and prescriptions. Data Collection Using an iterative matching approach, this study identifies physicians who delivered outpatient Medicare services in 2014 (n = 409 041) and tracks their annual transfers between 2014 and 2016 (N = 1 227 123) across six transfer categories. In addition, it examines their Medicare Part D prescription behavior between 2014 and 2015 (N = 741 659). Principal Findings Industry transfers dramatically declined in 2015 and 2016. Transfers are significantly associated with increased prescription costs, branded prescribing, and prescribing for High‐Risk Medications (HRMs). Conclusions Industry transfers have declined after public reporting. Transfers are associated with higher prescription costs and incidence of HRMs. Future research is needed to determine the causal impact on quality and cost‐effectiveness of prescribed medications.

show abstract

Section: Existing Literaturementioning

confidence: 99%

Physician characteristics, industry transfers, and pharmaceutical prescribing: Empirical evidence from medicare and the physician payment sunshine act

Brunt

2018

Health Services Research

View full text Add to dashboard Cite

show abstract

“…We used a recent observational retrospective stud focusing on industry payments to physicians by specialty for comparison data. 16 Simple descriptive statistics were used for data analysis. Total payments of each type (total general payments, direct total research payments, and indirect associated research funding) averaging complete 2014 to 2016 data are detailed in Table 1 below.…”

Section: Outcome Measuresmentioning

confidence: 99%

“…We hypothesized that physician journal editors would have a non-negligible rate of financial COI though lower than the estimated rate among clinicians in the field, previously established using the same data source. 16 …”

Section: Introductionmentioning

confidence: 99%

Industry payments to physician journal editors

Wong

Avalos

Callaham

2017

Preprint

View full text Add to dashboard Cite

Objective: To assess industry payments to physician journal editors, and determine how their financial conflict of interest rate compares to all physicians within the specialty.Study Design and Setting: Open Payments is a United States federal program that mandates reporting of medical industry payments to physicians. We performed a retrospective analysis of prospectively collected data, reviewing August 1, 2013 to December 31, 2016 payments using the Open Payments search tool. We collected payments data on "top tier" US-based physician-editors of highly-cited medical journals including 1) total general payments from industry, 2) total "direct" research payments, and 3) associated "indirect" research funding. We compared payments to physician-editors and payments to physicians-by-specialty using existing published data.Results: In 35 journals, 333 (74.5%) of 447 "top tier" editors met inclusion criteria as US-based physician-editors. Of these, 212 (63.7%) received any industry-associated payments in the study period.In an average year during the study period, 141 (42.3%) of physician-editors received any payments directed to themselves (rather than their institutions), 120 (36.0%) received payments >$50; 66 (19.8%) received payments >$5,000 (the threshold designated by the National Institutes of Health as a Significant Financial Interest); and 51 (15.3%) received payments >$10,000. Mean annual payment of "total general payments" was $55,157 (standard deviation 561,885, range 10-10,981,153) with median of $3,512. Median general industry payments to physician-editors were mostly higher compared to all physicians within their specialty.Conclusions: A substantial minority of physician-editors receive direct payments from industry within any given year, though most editors received payment of some kind in the study period. There were significant outliers. More robust and specific editor financial COI declarations may be appropriate given the extent of editors' influences on the medical literature.

show abstract

“…According to the Physician Payments Sunshine Act, a component of the 2010 Affordable Care Act, all pharmaceutical and manufacturers of medical devices must publicly report payments to physicians and teaching hospitals that are at least $10 in value on the Centers for Medicare and Medicaid Services website . According to this database, called Open Payments, the median value of general payments made to emergency medicine physicians by industry in 2015 was $50 with an interquartile range of $18 to $125 …”

mentioning

confidence: 99%